BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.13% | 60.80% | -71.30% | 15.97% | 38.76% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | -74.74% | 101.25% | -194.97% |
| Total Other Non-Cash Items | 1.05% | -1.07% | 21.53% | -76.80% | 484.67% |
| Change in Net Operating Assets | -466.85% | 135.11% | -3,040.65% | 91.65% | -191.05% |
| Cash from Operations | -347.35% | 85.40% | -139.83% | 10.66% | 31.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -34.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | 622.27% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 5,482.69% | 90.36% | -115.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -347.35% | -128.61% | 214.70% | 41.28% | -164.27% |